Cao YB - Search Results

1

[A retrospective study of postoperative adjuvant therapy following immunotherapy combined with targeted therapy and sequential curative surgical procedures for initially unresectable hepatocellular carcinoma].

Ran ZK, Tang HW, Cao YB, Zhang WW, Liu Z, Wan T, Li XR, Li JF, Jiao TY, Lu SC. Ran ZK, et al. Among authors: cao yb. Zhonghua Wai Ke Za Zhi. 2024 Jun 1;62(6):543-548. doi: 10.3760/cma.j.cn112139-20240207-00068. Zhonghua Wai Ke Za Zhi. 2024. PMID: 38682625 Chinese.

2

[Curative efficacy analysis of allo-HSCT using conditioning regimen of FLAG combined with modified BUCY for refractory and relapsed patients with hematologic malignancies].

Wang ZH, Wu XX, Liu ZY, Ma J, Cao YB, Xu LX, Wu YM, Liu B, Yan B, DA WM. Wang ZH, et al. Among authors: cao yb. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):158-62. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21362243 Chinese.

3

Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.

Xu L, Liu Z, Wu Y, Yang X, Cao Y, Li X, Yan B, Li S, Da W, Wu X. Xu L, et al. Eur J Med Res. 2018 Mar 1;23(1):12. doi: 10.1186/s40001-018-0311-3. Eur J Med Res. 2018. PMID: 29490698 Free PMC article.

4

[Efficacy of haploidentical allogeneic bone marrow hematopoietic stem cell transplantation combined with umbilical cord blood derived mesenchymal stem cells for severe aplastic anemia].

Xu LX, Cao YB, Wang ZH, Liu ZY, Liu B, Zhao DD, DA WM, Gao CJ, Wu XX. Xu LX, et al. Among authors: cao yb. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Oct;19(5):1241-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 22040980 Chinese.

5

RETRACTED ARTICLE: Cotransplantation of human umbilical cord mesenchymal and haplo-hematopoietic stem cells in patients with severe aplastic anemia.

Xu L, Liu Z, Wu Y, Yang X, Cao Y, Li X, Yan B, Li S, Da W, Wu X. Xu L, et al. Cytotechnology. 2016 Jan;68(1):177. doi: 10.1007/s10616-014-9793-1. Epub 2015 Aug 17. Cytotechnology. 2016. PMID: 25407730 Free PMC article. No abstract available.

6

[Efficacy of donor's purified CD34(+) cells for treatment of poor graft function following allogeneic hematopoietic stem cell transplantation].

Li ZH, Wu XX, Cao YB, Li XH, Wu YM, Liu P, Xu LX, Yan P, Liu ZY, Li SW, Yang XL. Li ZH, et al. Among authors: cao yb. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1228-31. doi: 10.7534/j.issn.1009-2137.2013.05.029. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24156440 Chinese.

7

[Prediction of the GVHD after allo-HSCT by sequence similar matching method].

Zhao DD, Liu ZY, Cao YB, Jiang S, DA WM, Wu XX. Zhao DD, et al. Among authors: cao yb. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):740-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20561441 Chinese.

8

[Clinical Efficacy of Autologous Hematopoietic Stem Cell Transplantation Using Tumor-ablative Conditioning Regimen for Patients with Refractory/Relapsed Non-Hodgkin's Lymphoma].

Yang XL, Wu YM, Cao YB, Li XH, Xu LX, Liu ZY, Liu B, Yan B, Li SW, DA WM, Wu XX. Yang XL, et al. Among authors: cao yb. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Dec;24(6):1743-1747. doi: 10.7534/j.issn.1009-2137.2016.06.023. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 28024487 Chinese.

9

Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy.

Wu Y, Wang Z, Cao Y, Xu L, Li X, Liu P, Yan P, Liu Z, Zhao D, Wang J, Wu X, Gao C, Da W, Han Z. Wu Y, et al. Ann Hematol. 2013 Dec;92(12):1675-84. doi: 10.1007/s00277-013-1831-0. Epub 2013 Jul 11. Ann Hematol. 2013. PMID: 23842707

10

[Clinical study on recombinant humanized anti-CD25 monoclonal antibody used for treating steroid-resistant acute graft versus host disease following allo-hematopoietic stem cell transplantation].

Li XH, Gao CJ, DA WM, Cao YB, Xu LX, Wu YM, Liu B, Liu ZY, Yan B, Li SW, Yang XL, Wu XX. Li XH, et al. Among authors: cao yb. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1535-40. doi: 10.7534/j.issn.1009-2137.2013.06.032. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370044 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page